The field is born.
Dr. H. Sherwood Lawrence at NYU School of Medicine identifies transfer factors — naturally occurring polypeptides that carry immune information between organisms. A new category of immunology is established.
Four decades of research.
Transfer factors are studied extensively in academic and clinical settings. Thousands of peer-reviewed papers accumulate across universities, hospitals, and research institutions — establishing the rigor the category now stands on.
4Life brings transfer factor to the world.
David and Bianca Lisonbee found 4Life Research and launch the first commercial transfer factor product — sourced from bovine colostrum — transforming a clinical niche into an accessible wellness category.
Avian transfer factor.
4Life pioneers the extraction of transfer factors from chicken egg yolks, broadening the immune-information footprint and unlocking new formulation possibilities.
Transfer Factor E-XF™ patent granted.
The U.S. Patent on 4Life's proprietary extraction and concentration process makes the category defensible. Competitors can't legally replicate what 4Life makes — a moat that still protects the business today.
Tri-Factor Formula — a first in the category.
4Life launches the world's first formulation combining bovine and avian transfer factors in a single product — delivering complementary immune information that no other company can match.
Global expansion.
4Life expands to 50+ countries and crosses billions in lifetime commissions. Manufacturing, research, and distribution infrastructure mature into a truly vertically integrated business.
The wellness world discovers peptides — 28 years late.
Peptides become the trend of the decade. For 4Life, it's nothing new — transfer factors are naturally occurring polypeptides, and the company has been delivering immune peptides since 1998. The broader market finally catches up. The portfolio keeps expanding.
PhytoFactor® — the next first.
4Life launches the world's first plant-based transfer factor. A scientific breakthrough that opens vegan, vegetarian, and plant-first markets previously beyond reach — and proves the science is still just getting started.